Artwork

内容由Meryl Comer, UsAgainstAlzheimer's and Meryl Comer提供。所有播客内容(包括剧集、图形和播客描述)均由 Meryl Comer, UsAgainstAlzheimer's and Meryl Comer 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Ep 64: Dr. Suzanne LeBlang – Focused Ultrasound Technology and Alzheimer’s Treatment (part 2)

13:00
 
分享
 

Manage episode 421878877 series 41856
内容由Meryl Comer, UsAgainstAlzheimer's and Meryl Comer提供。所有播客内容(包括剧集、图形和播客描述)均由 Meryl Comer, UsAgainstAlzheimer's and Meryl Comer 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger

Support the show

  continue reading

60集单集

Artwork
icon分享
 
Manage episode 421878877 series 41856
内容由Meryl Comer, UsAgainstAlzheimer's and Meryl Comer提供。所有播客内容(包括剧集、图形和播客描述)均由 Meryl Comer, UsAgainstAlzheimer's and Meryl Comer 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

Join us for part 2 of BrainStorm’s interview with Dr. Suzanne LeBlang, Director of Clinical Relations at Focused Ultrasound Foundation (www.fusfoundation.org). Host Meryl Comer and Dr. LeBlang discuss eligibility criteria and applications for the ground-breaking technology of focused ultrasound – a non-invasive procedure for treating tremors in Parkinson’s disease and those newly diagnosed with Alzheimer’s disease. This technological advancement can target and treat tissue deep within the brain, enhance drug delivery, and facilitate the removal of amyloid plaques. As featured on CBS 60 Minutes, patients are awake during this transformational procedure. You won’t want to miss part 2 of this interview!
Produced by Susan Quirk and Amber Roniger

Support the show

  continue reading

60集单集

Все серии

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放